Unlock instant, AI-driven research and patent intelligence for your innovation.
Medicine for treating hysteromyoma, ovarian cyst and endometriosis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technique for ovarian cysts and endometrium, which is applied to the drugs for ovarian cysts and endometriosis, and the field of treatment of uterine fibroids to achieve the effect of symptom disappearance
Inactive Publication Date: 2015-07-22
赵汝君 +1
View PDF9 Cites 6 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Drug therapy includes: estrogen suppression, gonadotropin-releasing hormone agonists or antagonists, androgens, and progestogens, but all have certain side effects
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0031] A kind of medicine for the treatment of uterine fibroids, ovarian cyst and endometriosis, is characterized in that, comprises following raw material ratio by weight:
[0032] 15 parts of angelica, 15 parts of peony, 15 parts of cassiatwig, 15 parts of zedoary, 15 parts of Moutan bark, 20 parts of licorice, 9 parts of peach kernel, 6 parts of safflower, 5 parts of Sanleng, 15 parts of Dipsacus, 10 parts of Wulingzhi 6 servings of dried blood, 20 servings of mugwort leaves, and 9 servings of leeches.
[0033] Decocted into decoction orally according to the conventional method.
Embodiment 2
[0035] A kind of medicine for the treatment of uterine fibroids, ovarian cyst and endometriosis, is characterized in that, comprises following raw material ratio by weight:
[0036] 20 parts of angelica, 15 parts of peony, 20 parts of cassiatwig, 15 parts of curcuma, 15 parts of Moutan bark, 20 parts of licorice, 9 parts of peach kernel, 9 parts of safflower, 15 parts of Sanleng, 15 parts of Dipsacus sichuan, 10 parts of Wulingzhi 9 parts, 9 parts of dried blood, 20 parts of Artemisia argyi leaves, 9 parts of leeches.
[0037] Decocted into decoction orally according to the conventional method.
Embodiment 3
[0039] A kind of medicine for the treatment of uterine fibroids, ovarian cyst and endometriosis, is characterized in that, comprises following raw material ratio by weight:
[0040]15 parts of angelica, 20 parts of peony, 15 parts of cassia twig, 20 parts of zedoary, 15 parts of Moutan bark, 20 parts of licorice, 9 parts of peach kernel, 9 parts of safflower, 15 parts of Sanleng, 10 parts of Dipsacus, 10 parts of Wulingzhi 9 parts of dried blood, 20 parts of mugwort leaves, 12 parts of leeches.
[0041] Decocted into decoction orally according to the conventional method.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention provides a medicine for treating hysteromyoma, ovarian cyst and endometriosis. The medicine is prepared from the following components in parts by weight: 10-40 parts of angelica sinensis, 10-40 parts of paeony, 10-40 parts of cassiatwig, 10-40 parts of curcuma zedoary, 10-40 parts of moutan bark, 10-50 parts of liquorice, 6-24 parts of peach kernel, 6-24 parts of flos carthami, 3-15 parts of rhizoma sparganii, 10-40 parts of dipsacus asper, 5-25 parts of trogopterus dung, 3-15 parts of daemonorops draco, 10-50 parts of folium artemisiae argyi and 6-24 parts of leech. The medicine for treating hysteromyoma, ovarian cyst and endometriosis is less in damages and small in side effects, and is capable of treating both symptoms and root causes.
Description
technical field [0001] The invention belongs to the field of traditional Chinese medicines, in particular to a medicine for treating uterine fibroids, ovarian cysts and endometriosis. Background technique [0002] Uterine fibroids and ovarian cysts are common gynecological diseases that usually occur between the ages of 30 and 50. The main symptoms are: abdominal distension, abdominal pain, frequent urination, urgency, irregular vaginal bleeding leading to excessive menstrual bleeding for too long. Abdominal distension and abdominal pain are the most serious during menstruation, accompanied by symptoms such as bleeding and loss of libido during sexual intercourse. The severity of symptoms has a certain relationship with the size of fibroids and the location of growth. [0003] Endometriotic tissue contains receptors for estrogen and progesterone, allowing it to grow and differentiate in response to changes in hormone levels during the menstrual cycle. Endometriosis is usu...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.